Table 5.
Decision making in elderly AML based on expected outcomes
| Induction Mortality |
CR Rate | 3-year Survival | Conventional Chemotherapy |
|---|---|---|---|
| < 15% | > 40% | > 15% | YES |
| > 30% | < 20% | < 10% | NO* |
| 15-30% | 20-40% | > 10% | ?** |
Clinical trials of novel, investigational agents recommended
Clinical trials comparing standard regimens to new strategies recommended CR = complete remission